Integra Q3 2026 revenues rise on organic growth, adjusted EPS $0.59
Integra LifeSciences reported a 2.5% organic revenue increase to $411.2M and adjusted EPS of $0.59, though results were impacted by a recent Cincinnati facility flood. The company also completed a $2.1 billion debt refinancing and maintained 2026 financial guidance.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed